Difference between revisions of "Template:Hormone levels with rectal progesterone"
Jump to navigation
Jump to search
Template documentation
imported>Aphistic m (Fix reversed captions for the graphs and citations.) |
imported>Boghog (consistent citation formatting) |
||
| Line 5: | Line 5: | ||
| style="font-size:small;" | | style="font-size:small;" | ||
| − | | File:Progesterone levels with 100 mg rectal or vaginal progesterone in women.png | Progesterone levels with vaginal or rectal administration of a suppository containing 100 mg progesterone (P4) in women.<ref name="pmid3612635">{{cite journal | vauthors = Chakmakjian ZH, Zachariah NY | title = Bioavailability of progesterone with different modes of administration | journal = | + | | File:Progesterone levels with 100 mg rectal or vaginal progesterone in women.png | Progesterone levels with vaginal or rectal administration of a suppository containing 100 mg progesterone (P4) in women.<ref name="pmid3612635">{{cite journal | vauthors = Chakmakjian ZH, Zachariah NY | title = Bioavailability of progesterone with different modes of administration | journal = The Journal of Reproductive Medicine | volume = 32 | issue = 6 | pages = 443–8 | date = June 1987 | pmid = 3612635 | doi = }}</ref> |
| − | | File:Progesterone levels with a single 25 or 100 mg rectal suppository in women.png | Progesterone levels with rectal administration of a suppository containing 25 or 100 mg progesterone (P4) in women.<ref name="pmid5582003">{{cite journal | vauthors = Nillius SJ, Johansson ED | title = Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone | journal = | + | | File:Progesterone levels with a single 25 or 100 mg rectal suppository in women.png | Progesterone levels with rectal administration of a suppository containing 25 or 100 mg progesterone (P4) in women.<ref name="pmid5582003">{{cite journal | vauthors = Nillius SJ, Johansson ED | title = Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone | journal = American Journal of Obstetrics and Gynecology | volume = 110 | issue = 4 | pages = 470–7 | date = June 1971 | pmid = 5582003 | doi = 10.1016/0002-9378(71)90686-7 }}</ref> |
}}}}<!-- | }}}}<!-- | ||
--><noinclude>{{Documentation|content= | --><noinclude>{{Documentation|content= | ||
| − | ==See also== | + | == See also == |
* [[Pharmacokinetics of progesterone#Rectal administration|Pharmacokinetics of progesterone § Rectal administration]] | * [[Pharmacokinetics of progesterone#Rectal administration|Pharmacokinetics of progesterone § Rectal administration]] | ||
| − | ==References== | + | == References == |
{{Reflist}} | {{Reflist}} | ||
}} | }} | ||
Revision as of 15:27, 19 August 2020
- Hormone levels with rectal progesterone
See also
References
- ↑ Chakmakjian ZH, Zachariah NY (June 1987). "Bioavailability of progesterone with different modes of administration". The Journal of Reproductive Medicine. 32 (6): 443–8. PMID 3612635.
- ↑ Nillius SJ, Johansson ED (June 1971). "Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone". American Journal of Obstetrics and Gynecology. 110 (4): 470–7. doi:10.1016/0002-9378(71)90686-7. PMID 5582003.
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |

